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Many modern diagnostic tests require the fast and accurate determination of the 
presence of certain proteins (biomarkers) in blood or other patient samples. 
Depending on the expected diagnosis a specific set of different biomarkers is 
usally needed in order to make a reliable decision on how to proceed in terms of 
further tests or therapy. For this purpose, we are developing a highly flexible 
biosensing platform using silicon nanoribbons in a field effect transistor 
configuration. Different aspects of the translation of the biosensor into an 
autonomous point-of-care device are being addessed.
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etching starts at the injection of HF 
and continues during the time in 
air, probably due to HF remaining 
on the surface and in the material
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longer etching phase leads to 
complete loss of conduction
due to decomposition of poly-
silicon in the nanoribbons
monitoring surface preparation
The graphs show the recorded current through the nanoribbon during 
oxide removal and polysilicon etching in aqueous 1% HF solution for 
different etching times.
simultaneous reagent delivery 
to 4 sensors in two flow paths
flowcell with reagent
mixing driven by gravity
simple flowcell
to interface the sensor chip
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silicon surface modification A
The images show functionalization layers of 1,7-Octadiyne labeled 
with a Fluorophore-Azide using a copper catalyzed Azide-Alkyne 
cycloaddition CuAAC 
on a) silicon surfaces (scratched to present different cystal surface 
orientations)
and b) polysilicon nanoribbons
silicon surface modification B
The images show the result of the binding of a fluorescently labeled 
goat anti-mouse antibody to an immobilized mouse-antibody. The 
surface has been modified with an alkyne presenting a BOC 
protected amino group. An the antibody was then immobilized by 
EDC/NHS aminocoupling after removal of the BOC group.
neg. control 200 mM 1 M
neg. control 
(no BOC removal)
neg. control 
(immob. albumin)
mouse-goat 
antibody coupling
plasma extraction filter
The image shows a simple device employing a membrane filter to 
remove cells from a small blood sample to extract the plasma and 
realese it into a stream of buffer. In this way the buffer can be 
adjusted to increase sensitivity.
The microscope images show the receding meniscus of the blood 
sample, as the plasma is removed and the only the cells remain.
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antibody detection
The graph shows the detection signal as the differential conductance 
measured for different concentrations of the second antibody as 
analyte..
passive flow control and self-terminating 
functionalization by capillary/gravitational forces
     two functionalization schemes have been 
demonstated for the direct attachment of proteins to 
a poly-silicon nanoribbon surface.
     surface modification and analyte attachement 
can be monitored electrically.
     devices for plasma extraction from small blood 
samples are being investigated
undiluted plasma extraction using a receptor pad 
and capillary networks
improved sensor design to enable 
multiplexing using several flow paths
optimization of the functionalization protocol for 
improved sensitivity
biomarker detection - NKG2D (immun 
cell receptor) ligands and hypoxia marker CA9 
are under investigation as potential cancer 
markers. Sensor functionalization with these 
proteins is currently tested.
